A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Behavioral Disturbances in Patients With Dementia
Clinical trial NCT00253123 · COMPLETED
Trial details
- NCT number
- NCT00253123
- Sponsor
- Janssen, LP
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Enrollment
- 626
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.